NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

寵物的癌症治療藥的全球市場:地區的展望、成長的潛在性、價格趨勢、市場佔有率、市場預測

Pet Cancer Therapeutics Market Size By Medicine Type, By Species, By Cancer Type, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025

出版商 Global Market Insights Inc. 商品編碼 820612
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
寵物的癌症治療藥的全球市場:地區的展望、成長的潛在性、價格趨勢、市場佔有率、市場預測 Pet Cancer Therapeutics Market Size By Medicine Type, By Species, By Cancer Type, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025
出版日期: 2019年03月01日內容資訊: 英文 120 Pages
簡介

本報告提供全球寵物癌症治療藥的市場調查,產業的背景、轉變,相關法律,技術環境,開發平台分析,產業的各種影響因素分析,各藥物區分、寵物區分、癌症類型、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等資訊彙整。

第1章 調查手法

第2章 摘要整理

第3章 寵物的癌症治療藥:產業分析

  • 產業區分
  • 產業環境的變化、預測
  • 產業影響因素
    • 成長推動因素
    • 課題
  • 成長的潛在性分析
  • 法律制度
  • 技術環境
  • 開發平台分析
  • 波特分析
  • 競爭環境
  • PESTEL分析

第4章 寵物的癌症治療藥市場分析、預測:各藥物種類

  • 主要趨勢
  • 化療藥
  • 疫苗

第5章 寵物的癌症治療藥市場分析、預測:寵物區分

  • 主要趨勢

第6章 寵物的癌症治療藥市場分析、預測:各癌症類型

  • 主要趨勢
  • 淋巴瘤
  • 肥胖細胞腫
  • 黑色素瘤
  • 乳腺、鱗狀細胞癌
  • 其他

第7章 寵物的癌症治療藥市場分析、預測:各地區、主要國家

  • 主要趨勢
  • 北美
  • 歐洲
  • 亞太地區
  • 南美

第8章 企業簡介

  • AB Science
  • Aratana Therapeutics
  • Canfel Therapeutics
  • Karyopharms Therapeutics
  • Merial Inc.
  • Oasmia Pharmaceuticals AB
  • Regeneus
  • VetiVax
  • VetDC, Inc.
  • Zoetis
目錄
Product Code: 2017

Title:
Pet Cancer Therapeutics Market Size By Medicine Type (Chemotherapy Drugs, Vaccines), By Species (Dogs, Cats), By Cancer Type (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, Brazil, Mexico), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025.

Pet Cancer Therapeutics Market will exceed USD 359.4 million by 2025; as per a new research report.

Growing willingness to spend on pet healthcare will boost pet cancer therapeutics market growth. As per American Society for the Prevention of Cruelty to Animals(ASPCA), American pet owner spend an average of USD 235 per year on dogs' health and USD 160 on cats' health. As pet owners spend more on pet care, the demand for pet cancer therapeutics will grow in the future.

Increasing number of pet owners and pet population will spur industry growth across the forecast timeframe. This is largely because of increasing need for companionship commonly seen in developed countries. Every year, nearly 2% of increase in pet ownership is seen, resulting to growing demand for pet cancer therapeutics.

Chemotherapy dominated the overall market and will reach USD 211.0 million by 2025. High growth is due to considerable number of products available for the control of tumor growth and is preferred in the form of intravenous administration and some are available in the form of oral administrations.

Dogs dominate the overall pet cancer therapeutics market due to increasing demand for adoption of dogs, willingness of pet owners to provide quality pet care and veterinary treatment, specialty foods and supplements. Furthermore, prevalence of cancer is more in dogs as compared to cats.

Lymphoma dominated the overall pet cancer drugs market and is expected to grow at 19.1% CAGR across the forecast timeframe. Considerable number of products available for the treatment of this cancer that attack pets such as dogs and cats. Lymphoma is the most common type of cancer found in dogs and cats, thereby leading to market growth.

UK pet cancer therapeutics market is estimated to reach USD 14.3 million by 2025. Pet cancer vaccines were available in most of the European regions before chemotherapy drugs. Vaccines market is likely to witness strong growth owing to introduction of new vaccines over the forecast period.

China pet cancer therapeutics market will expand at 12.6% CAGR across the forecast timeframe. Increasing population of dogs, increasing incidence of cancer in dogs, and increasing disposable income of dog owners is stimulating the further growth of pet cancer therapeutics market in China. As a result, the pet cancer treating drugs have been in great demand lately.

Few of the prominent market players involved in global pet cancer therapeutics market are Zoetis, Merial, Aratana Therapeutics, AB Science, Vetivax, VetDC, Regeneus and Karyopharms Verdinexor. The industry participants are engaged in acquisition and collaborations to enhance their market foothold and expand geographic reach.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definition
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Pet cancer therapeutics industry 360 degree synopsis, 2014 - 2025
    • 2.1.1. Business trends
    • 2.1.2. Medicine type trends
    • 2.1.3. Species trends
    • 2.1.4. Cancer type trends
    • 2.1.5. Regional trends

Chapter 3. Pet Cancer Therapeutics Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2014 - 2025
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Increasing pet population in the U.S. and Europe
      • 3.3.1.2. Rising prevalence of pet cancer in developed countries
      • 3.3.1.3. Rising awareness of pet owners regarding pet diseases and growing willingness to spend on pet healthcare
      • 3.3.1.4. Growing trend towards new product development
    • 3.3.2. Industry pitfalls & challenges
      • 3.3.2.1. Undesirable effects of pet cancer therapeutics
      • 3.3.2.2. Dearth of veterinary oncologist
      • 3.3.2.3. Low out of pocket expenditure on pet healthcare in developing countries
  • 3.4. Growth potential analysis
    • 3.4.1. By medicine type
    • 3.4.2. By species
    • 3.4.3. By cancer type
  • 3.5. Regulatory landscape
    • 3.5.1. U.S.
    • 3.5.2. Europe
  • 3.6. Technology landscape
    • 3.6.1. U.S.
    • 3.6.2. Europe
  • 3.7. Pipeline analysis
  • 3.8. Porter's analysis
  • 3.9. Competitive landscape, 2017
    • 3.9.1. Strategy dashboard
  • 3.10. PESTEL analysis

Chapter 4. Pet Cancer Therapeutics Market, By Medicine Type

  • 4.1. Key segment trends
  • 4.2. Chemotherapy drugs
    • 4.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 4.3. Vaccines
    • 4.3.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 5. Pet Cancer Therapeutics Market, By Species

  • 5.1. Key segment trends
  • 5.2. Dogs
    • 5.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 5.3. Cats
    • 5.3.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 6. Pet Cancer Therapeutics Market, By Cancer Type

  • 6.1. Key segment trends
  • 6.2. Lymphoma
    • 6.2.1. Market size, by region, 2014 - 2025 (USD Million)
  • 6.3. Mast cell cancer
    • 6.3.1. Market size, by region, 2014 - 2025 (USD Million)
  • 6.4. Melanoma
    • 6.4.1. Market size, by region, 2014 - 2025 (USD Million)
  • 6.5. Mammary and Squamous Cell Cancer
    • 6.5.1. Market size, by region, 2014 - 2025 (USD Million)
  • 6.6. Others
    • 6.6.1. Market size, by region, 2014 - 2025 (USD Million)

Chapter 7. Pet Cancer Therapeutics Market, By Region

  • 7.1. Key regional trends
  • 7.2. North America
    • 7.2.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.2.2. Market size, by medicine type, 2014 - 2025 (USD Million)
    • 7.2.3. Market size, by species, 2014 - 2025 (USD Million)
    • 7.2.4. Market size, by cancer type, 2014 - 2025 (USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market size, by medicine type, 2014 - 2025 (USD Million)
      • 7.2.5.2. Market size, by species, 2014 - 2025 (USD Million)
      • 7.2.5.3. Market size, by cancer type, 2014 - 2025 (USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market size, by medicine type, 2014 - 2025 (USD Million)
      • 7.2.6.2. Market size, by species, 2014 - 2025 (USD Million)
      • 7.2.6.3. Market size, by cancer type, 2014 - 2025 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.3.2. Market size, by medicine type, 2014 - 2025 (USD Million)
    • 7.3.3. Market size, by species, 2014 - 2025 (USD Million)
    • 7.3.4. Market size, by cancer type, 2014 - 2025 (USD Million)
    • 7.3.5. Germany
      • 7.3.5.1. Market size, by medicine type, 2014 - 2025 (USD Million)
      • 7.3.5.2. Market size, by species, 2014 - 2025 (USD Million)
      • 7.3.5.3. Market size, by cancer type, 2014 - 2025 (USD Million)
    • 7.3.6. UK
      • 7.3.6.1. Market size, by medicine type, 2014 - 2025 (USD Million)
      • 7.3.6.2. Market size, by species, 2014 - 2025 (USD Million)
      • 7.3.6.3. Market size, by cancer type, 2014 - 2025 (USD Million)
    • 7.3.7. France
      • 7.3.7.1. Market size, by medicine type, 2014 - 2025 (USD Million)
      • 7.3.7.2. Market size, by species, 2014 - 2025 (USD Million)
      • 7.3.7.3. Market size, by cancer type, 2014 - 2025 (USD Million)
    • 7.3.8. Spain
      • 7.3.8.1. Market size, by medicine type, 2014 - 2025 (USD Million)
      • 7.3.8.2. Market size, by species, 2014 - 2025 (USD Million)
      • 7.3.8.3. Market size, by cancer type, 2014 - 2025 (USD Million)
    • 7.3.9. Italy
      • 7.3.9.1. Market size, by medicine type, 2014 - 2025 (USD Million)
      • 7.3.9.2. Market size, by species, 2014 - 2025 (USD Million)
      • 7.3.9.3. Market size, by cancer type, 2014 - 2025 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.4.2. Market size, by medicine type, 2014 - 2025 (USD Million)
    • 7.4.3. Market size, by species, 2014 - 2025 (USD Million)
    • 7.4.4. Market size, by cancer type, 2014 - 2025 (USD Million)
    • 7.4.5. China
      • 7.4.5.1. Market size, by medicine type, 2014 - 2025 (USD Million)
      • 7.4.5.2. Market size, by species, 2014 - 2025 (USD Million)
      • 7.4.5.3. Market size, by cancer type, 2014 - 2025 (USD Million)
    • 7.4.6. India
      • 7.4.6.1. Market size, by medicine type, 2014 - 2025 (USD Million)
      • 7.4.6.2. Market size, by species, 2014 - 2025 (USD Million)
      • 7.4.6.3. Market size, by cancer type, 2014 - 2025 (USD Million)
    • 7.4.7. Japan
      • 7.4.7.1. Market size, by medicine type, 2014 - 2025 (USD Million)
      • 7.4.7.2. Market size, by species, 2014 - 2025 (USD Million)
      • 7.4.7.3. Market size, by cancer type, 2014 - 2025 (USD Million)
    • 7.4.8. Australia
      • 7.4.8.1. Market size, by medicine type, 2014 - 2025 (USD Million)
      • 7.4.8.2. Market size, by species, 2014 - 2025 (USD Million)
      • 7.4.8.3. Market size, by cancer type, 2014 - 2025 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.5.2. Market size, by medicine type, 2014 - 2025 (USD Million)
    • 7.5.3. Market size, by species, 2014 - 2025 (USD Million)
    • 7.5.4. Market size, by cancer type, 2014 - 2025 (USD Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Market size, by medicine type, 2014 - 2025 (USD Million)
      • 7.5.5.2. Market size, by species, 2014 - 2025 (USD Million)
      • 7.5.5.3. Market size, by cancer type, 2014 - 2025 (USD Million)
    • 7.5.6. Mexico
      • 7.5.6.1. Market size, by medicine type, 2014 - 2025 (USD Million)
      • 7.5.6.2. Market size, by species, 2014 - 2025 (USD Million)
      • 7.5.6.3. Market size, by cancer type, 2014 - 2025 (USD Million)

Chapter 8. Company Profiles

  • 8.1. AB Science
    • 8.1.1. Business overview
    • 8.1.2. Financial data
    • 8.1.3. Product landscape
    • 8.1.4. Strategic outlook
    • 8.1.5. SWOT analysis
  • 8.2. Aratana Therapeutics
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. Canfel Therapeutics
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. Karyopharms Therapeutics
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. Merial Inc.
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. Oasmia Pharmaceuticals AB
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Regeneus
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. VetiVax
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. VetDC, Inc.
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. Zoetis
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis

Data Tables

  • TABLE 1. Pet cancer therapeutics industry 360 degree synopsis, 2014 - 2025
  • TABLE 2. Global pet cancer therapeutics market size, 2014 - 2018, (USD Million)
  • TABLE 3. Global pet cancer therapeutics market size, 2019 - 2025, (USD Million)
  • TABLE 4. Global pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 5. Global pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 6. Global pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 7. Global pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 8. Global pet cancer therapeutics market size, by end-use, 2014 - 2018 (USD Million)
  • TABLE 9. Global pet cancer therapeutics market size, by end-use, 2019 - 2025 (USD Million)
  • TABLE 10. Global pet cancer therapeutics market size, by region, 2014 - 2018 (USD Million)
  • TABLE 11. Global pet cancer therapeutics market size, by region, 2019 - 2025 (USD Million)
  • TABLE 12. Industry impact forces
  • TABLE 13. Chemotherapy drugs market size, by region, 2014 - 2018, (USD Million)
  • TABLE 14. Chemotherapy drugs market size, by region, 2019 - 2025, (USD Million)
  • TABLE 15. Vaccines market size, by region, 2014 - 2018, (USD Million)
  • TABLE 16. Vaccines market size, by region, 2019 - 2025, (USD Million)
  • TABLE 17. Dogs market size, by region, 2014 - 2018, (USD Million)
  • TABLE 18. Dogs market size, by region, 2019 - 2025, (USD Million)
  • TABLE 19. Cats market size, by region, 2014 - 2018, (USD Million)
  • TABLE 20. Cats market size, by region, 2019 - 2025, (USD Million)
  • TABLE 21. Lymphoma market size, by region, 2014 - 2018, (USD Million)
  • TABLE 22. Lymphoma market size, by region, 2019 - 2025, (USD Million)
  • TABLE 23. Mast cell cancer market size, by region, 2014 - 2018, (USD Million)
  • TABLE 24. Mast cell cancer market size, by region, 2019 - 2025, (USD Million)
  • TABLE 25. WHO melanoma scaling system for diagnosis of disease stage
  • TABLE 26. Melanoma market size, by region, 2014 - 2018, (USD Million)
  • TABLE 27. Melanoma market size, by region, 2019 - 2025, (USD Million)
  • TABLE 28. Mammary and squamous cell cancer market size, by region, 2014 - 2018, (USD Million)
  • TABLE 29. Mammary and squamous cell cancer market size, by region, 2019 - 2025, (USD Million)
  • TABLE 30. Others market size, by region, 2014 - 2018, (USD Million)
  • TABLE 31. Others market size, by region, 2019 - 2025, (USD Million)
  • TABLE 32. North America pet cancer therapeutics market size, by country, 2014 - 2018 (USD Million)
  • TABLE 33. North America pet cancer therapeutics market size, by country, 2019 - 2025 (USD Million)
  • TABLE 34. North America pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 35. North America pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 36. North America pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 37. North America pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 38. North America pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 39. North America pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 40. U.S. pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 41. U.S. pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 42. U.S. pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 43. U.S. pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 44. U.S. pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 45. U.S. pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 46. Canada pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 47. Canada pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 48. Canada pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 49. Canada pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 50. Canada pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 51. Canada pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 52. Europe pet cancer therapeutics market size, by country, 2014 - 2018 (USD Million)
  • TABLE 53. Europe pet cancer therapeutics market size, by country, 2019 - 2025 (USD Million)
  • TABLE 54. Europe pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 55. Europe pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 56. Europe pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 57. Europe pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 58. Europe pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 59. Europe pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 60. Germany pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 61. Germany pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 62. Germany pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 63. Germany pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 64. Germany pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 65. Germany pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 66. UK pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 67. UK pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 68. UK pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 69. UK pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 70. UK pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 71. UK pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 72. France pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 73. France pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 74. France pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 75. France pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 76. France pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 77. France pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 78. Spain pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 79. Spain pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 80. Spain pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 81. Spain pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 82. Spain pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 83. Spain pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 84. Italy pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 85. Italy pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 86. Italy pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 87. Italy pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 88. Italy pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 89. Italy pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 90. Asia Pacific pet cancer therapeutics market size, by country, 2014 - 2018 (USD Million)
  • TABLE 91. Asia Pacific pet cancer therapeutics market size, by country, 2019 - 2025 (USD Million)
  • TABLE 92. Asia Pacific pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 93. Asia Pacific pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 94. Asia Pacific pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 95. Asia Pacific pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 96. Asia Pacific pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 97. Asia Pacific pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 98. China pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 99. China pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 100. China pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 101. China pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 102. China pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 103. China pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 104. India pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 105. India pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 106. India pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 107. India pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 108. India pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 109. India pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 110. Japan pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 111. Japan pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 112. Japan pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 113. Japan pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 114. Japan pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 115. Japan pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 116. Australia pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 117. Australia pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 118. Australia pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 119. Australia pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 120. Australia pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 121. Australia pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 122. Latin America pet cancer therapeutics market size, by country, 2014 - 2018 (USD Million)
  • TABLE 123. Latin America pet cancer therapeutics market size, by country, 2019 - 2025 (USD Million)
  • TABLE 124. Latin America pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 125. Latin America pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 126. Latin America pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 127. Latin America pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 128. Latin America pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 129. Latin America pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 130. Brazil pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 131. Brazil pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 132. Brazil pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 133. Brazil pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 134. Brazil pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 135. Brazil pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)
  • TABLE 136. Mexico pet cancer therapeutics market size, by medicine type, 2014 - 2018 (USD Million)
  • TABLE 137. Mexico pet cancer therapeutics market size, by medicine type, 2019 - 2025 (USD Million)
  • TABLE 138. Mexico pet cancer therapeutics market size, by species, 2014 - 2018 (USD Million)
  • TABLE 139. Mexico pet cancer therapeutics market size, by species, 2019 - 2025 (USD Million)
  • TABLE 140. Mexico pet cancer therapeutics market size, by cancer type, 2014 - 2018 (USD Million)
  • TABLE 141. Mexico pet cancer therapeutics market size, by cancer type, 2019 - 2025 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global pet cancer therapeutics market size, 2014 - 2025 (USD Million)
  • FIG. 3 Growth potential analysis, by medicine type
  • FIG. 4 Growth potential analysis, by species
  • FIG. 5 Growth potential analysis, by cancer type
  • FIG. 6 Porter's analysis
  • FIG. 7 Strategy dashboard
  • FIG. 8 PESTEL analysis